Cancer Biology & Medicine

Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis
Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
Insights into tertiary lymphoid structures in the solid tumor microenvironment
Tumorigenic bacteria in colorectal cancer mechanisms and treatments

Latest Articles

You have access
Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors
Yangling Li, Dongmei Zhou, Shuang Xu, Mingjun Rao, Zuoyan Zhang, Linwen Wu, Chong Zhang and Nengming Lin

Cancer Biology & Medicine July 2022, 19 (7) 1109-1110; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0172
You have access
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao, Qian Zhao, Ding Yan, Ziying Lei, Yali Hao, Jinghong Chen, Qian Xue, Xiaofen Li, Qingtian Huang, Daolin Tang, Q. Ping Dou, Xin Chen and Jinbao Liu

Cancer Biology & Medicine July 2022, 19 (7) 1061-1077; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0598
You have access
Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
Wuyin Wang, Lu Zhang and Zhijun Sun

Cancer Biology & Medicine July 2022, 19 (7) 948-964; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0049
You have access
SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation
Liao Wang, Yinghui Sun, Xijie Liu, Hongjuan Li, Chang Lu, Ronghui Yang, Chuanzhen Yang and Binghui Li

Cancer Biology & Medicine July 2022, 19 (7) 995-1007; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0291
You have access
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial
Jingjing Wu, Fenghua Gao, Wenhua Wang, Xudong Zhang, Meng Dong, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Linan Zhu, Mengjie Ding, Songtao Niu, Zhaoming Li, Yu Chang, Feifei Nan, Jiaqian Yan, Hui Yu, Xiaolong Wu, Zhiyuan Zhou, Jieming Zhang and Mingzhi Zhang

Cancer Biology & Medicine July 2022, 19 (7) 1089-1099; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0026
You have access
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng, Jing Wang, Kai Cheng, Qiqi Lu, Ru Zhao, Shiguan Wang, Qingyun Zhang, Luna Ge, Jihong Pan, Guanhua Song and Lin Wang

Cancer Biology & Medicine July 2022, 19 (7) 1008-1028; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0583